Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ
Closed
Aug 21, 2026
Day's Range
85.9452 wk Range
19.82Overview - ARWR - Arrowhead Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
12.08B
P/E (Trailing)
‪47.10‬
P/E (Forward)
‪-17.89‬
PEG Ratio
‪5.93‬
Price / Sales (TTM)
‪18.37‬
Price / Book
‪26.41‬
EV / EBITDA
‪-60.24‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.44M
Short % of Shares Outstanding
‪9.51%‬
Held by Insiders
‪3.65%‬
Held by Institutions
‪85.57%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪82.51‬
200-Day Avg
‪68.84‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪$ 110.18‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ARWR - Arrowhead Pharmaceuticals Inc.
Peers - ARWR - Arrowhead Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ARWRNASDAQArrowhead Pharmaceuticals Inc.12.30BMarket Cap+76.22%52-week change47.10P/E (Trailing)‪-47.79%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.60BMarket Cap-87.81%52-week change41.15P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+24.84%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.16P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ARWR - Arrowhead Pharmaceuticals Inc.
About
Arrowhead Pharmaceuticals is a biotechnology company focused on developing innovative medicines for intractable diseases. The company specializes in RNA interference (RNAi) therapeutics, a cutting-edge approach to treating genetic and metabolic disorders by targeting disease-causing proteins at the molecular level.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
